AMS electronic Patient Reported Outcomes (AMS-ePRO®)

AMS-ePRO® supports Clinical Research

You can now capture your patients data Anytime Anywhere with AMS-ePRO® to provide you with more clinically relevant data to help your trial move.

AMS has a 20 year success record of supporting many pharmaceutical, biotechnology and medical device companies in running clinical trials of all phases, indications and complexities. As clinical research evolves, and patient engagement is increasingly important, AMS has developed a fully validated electronic ePRO solution.

AMS-ePRO® system is a fully validated electronic solution which not only conforms with GCP and GDPR, but is flexible and more accommodating for the patients as they can utilize their own device. AMS has successfully utilized AMS-ePRO® in several studies in different indications.

AMS-ePRO® - flexible solutions

Collect what you want! Anywhere Anytime

Collect Patient Reported Outcomes:

  • Patient diaries: simple or complex
  • Quality of life or health related quality of life data. QOL, HQRL
  • Surveys
  • Geofencing, site-triggered calls, reminders.

Bring Your own Device – Concept

Internet-based Data Collection with patient own devices (e.g. smartphones, tablets or computers)

System fully validated

according to international computer system validation
standards (21 CFR part 11 and Annex 11)

System GDPR Compliant

in accordance with the Data Protection requirements (GDPR)


The collected data in AMS-ePRO® could be exported or reported based on client wishes.

Get in touch with us at:

• 2011 – AMS AMNOG Services pioneer • 2013 – AMS-Investigator SELF-TRAINING PORTAL • 2013 – “BEST CRO” by one of ther world’s Top 5 Pharma companies’ CRO Evaluation for AMS – Clinical Operations Services • 2014 – AMS performs Medical App Studies including eCRF-data integration • 2015 – AMS Medical Science is awarded “Provider of the Year, worldwide” the world’s Top 10 Pharma companies • 2015 – AMS develops an E-feasibility tool • 2015 – Innovative Tool for Patient Reported Outcomes: AMS-ePRO (BYOD-type PRO solution) is developed • 2016 – AMS – Regulatory Affairs is nominated on the short-list for TOPRA Award for Regulatory Excellence


  • EUnetHTA Open Call for Early Dialogue Requests

    EUnetHTA Open Call for Early Dialogue...

    Artikel vom 09 July 2020 News
    EUnetHTA’s Joint Action 3 has been prolonged to May 31, 2021. After a temporary suspension of Early Dialogues (ED) due to the current pandemic situation, ED...
  • EUnetHTA publishes the second iteration of the EUnetHTA Prioritisation List (EPL)

    EUnetHTA publishes the second...

    Artikel vom 01 August 2019 News
    It’s time to get involved: EUnetHTA publishes the second iteration of the EUnetHTA Prioritisation List (EPL) EUnetHTA’s Joint Action 3 will definitely end in...
  • EMA-EUnetHTA Parallel Consultation

    EMA-EUnetHTA Parallel Consultation

    Artikel vom 01 August 2017 News
    Profit from the simultaneous feedback of regulatory and HTA bodies in order to generate your data set in the most efficient way! What is new? EMA and EUnetHTA have...
  • AbbVie TRIUMPH AWARD 2015

    AbbVie TRIUMPH AWARD 2015

    Artikel vom 24 June 2016 News
    Um Kooperationen auszuzeichnen und Partner entsprechend zu honorieren, verleiht AbbVie Global jährlich den Preis 'Supplier of the Year'. Kriterien, um für den...